Trucept Adds Robbe to Board of Directors

March 1, 2021

SAN DIEGO, CA – May 21, 2021  –Trucept Inc.(OTC Pink: TREPTrucept Inc. has released its updated financials for Q1 2021. The company has experienced another consecutive quarter of profitability, as Trucept reported revenues of $3.8 million for the period (an increase from 48.76 percent over the previous year).

“We’re thrilled to have Fletcher join our Board of Directors,” said Chairman, Brian Bonar. “Securities law requires that independent members be seated on the board and he will help oversee management’s progress on the audit of Trucept’s financials,” Bonar added.

Robbe is pleased with the appointment as well and looks forward to working to grow the company. “I’m excited to be a part of this opportunity and I hope to help Trucept become an even bigger player in multiple marketplaces,” he said.

Robbe graduated from California State University Northridge with a B.A. in Political Science and received his J.D. at Southwestern University School of Law. He was admitted to the state bar of California in 1975 and formed Fletcher Robbe and Associates in 1975 which became Fletcher Robbe International Attorneys at Law in 1980. Robbe is admitted to the U.S. Federal District Court, Central District of California and the U.S. Court of Appeals, Ninth Circuit. He is also a member of the National Business Aviation Association.

For additional information, visit

About Trucept Inc.

Trucept Inc. is a renowned name in the business solutions sector, dedicated to helping companies focus on their core operations while it takes care of the peripheral business processes. With its extensive suite of services and a commitment to excellence, Trucept has been a trusted partner for countless businesses, aiding their growth and success.

For more information, call 858-798-1620 or visit


Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.

More Recent Articles

Trucept Inc. Achieves Remarkable Financial Milestones in 2023

Trucept Inc. Achieves Remarkable Financial Milestones in 2023

ESCONDIDO, CA  – March 25, 2024 –  Trucept Inc. (OTC Pink: TREP) is pleased to announce significant achievements in its financial performance for the fiscal year 2023. "We are thrilled to announce these outstanding financial achievements for the fiscal year 2023,"...

read more
Trucept Announces 427% Increase In Operating Income

Trucept Announces 427% Increase In Operating Income

SAN DIEGO, CA  – November 14th, 2023 –  Trucept Inc. (OTC Pink: TREP) Trucept has increased operating Income by 160% and 427% for the 3 and 9 months ending September 30, 2023 as compared to the same periods the prior year. Trucept has also increased Net Income by 130%...

read more